VRCA
Verrica Pharmaceuticals (VRCA)
$64
About Verrica Pharmaceuticals (VRCA)
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Details
Daily high
$6.19
Daily low
$5.63
Price at open
$5.63
52 Week High
$9.82
52 Week Low
$3.28
Market cap
96.7M
Dividend yield
0.00%
Volume
105,089
Avg. volume
37,358
P/E ratio
-5.44
Verrica Pharmaceuticals News
Details
Daily high
$6.19
Daily low
$5.63
Price at open
$5.63
52 Week High
$9.82
52 Week Low
$3.28
Market cap
96.7M
Dividend yield
0.00%
Volume
105,089
Avg. volume
37,358
P/E ratio
-5.44